Jones, Paul W <br/><br/>
The effect of aclidinium bromide on daily respiratory symptoms of COPD, measured using the Evaluating Respiratory Symptoms in COPD (E-RS: COPD) diary: pooled analysis of two 6-month Phase III studies.  [electronic resource] 

 -  Respiratory research  05 2016 
 - 61 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1465-993X 
<br/><br/><label>Standard No.: </label>10.1186/s12931-016-0372-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Inhalation<br/>Aged<br/>Bronchodilator Agents--administration & dosage<br/>Clinical Trials, Phase III as Topic<br/>Disease Progression<br/>Drug Administration Schedule<br/>Drug Therapy, Combination<br/>Female<br/>Forced Expiratory Volume<br/>Humans<br/>Lung--drug effects<br/>Male<br/>Middle Aged<br/>Multicenter Studies as Topic<br/>Muscarinic Antagonists--administration & dosage<br/>Pulmonary Disease, Chronic Obstructive--diagnosis<br/>Randomized Controlled Trials as Topic<br/>Recovery of Function<br/>Respiration--drug effects<br/>Severity of Illness Index<br/>Time Factors<br/>Treatment Outcome<br/>Tropanes--administration & dosage